Below is a list of Amgen-sponsored, disclosed clinical trials.
|A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis||Recruiting|
|A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis||Not yet recruiting|
|A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]||Recruiting|
|A Randomized, Double-Blind, Active-Controlled Phase 3 Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)||Recruitment Complete|
STELARA is a trademark of Janssen Biotech, Inc.
EYLEA is a trademark of Regeneron Pharmaceuticals, Inc.
SOLIRIS is a trademark of Alexion Pharmaceuticals, Inc.